Division of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, Canada.
Department of Biostatistics, Miller Scientific, Johnson City, Tennessee, USA.
J Endourol. 2021 Jul;35(7):991-1000. doi: 10.1089/end.2020.1133. Epub 2021 Mar 15.
Urosepsis is a serious potential complication of ureteroscopic procedures for stone disease, yet the risk factors for this complication are not well characterized. The purpose of this systematic review with meta-analysis was to identify potential risk factors for urosepsis after ureteroscopy (URS) for stone disease. We performed systematic searches of Medline, Embase, and the Cochrane Central Register of Controlled Trials for studies reporting at least one prospectively defined risk factor for urosepsis after URS. Studies that only reported rates of isolated fever, urinary tract infection (UTI), or pooled infectious complications were excluded. The risk factors evaluated in this review were age, sex, body mass index, diabetes mellitus, ischemic heart disease, recent UTI, pyuria, hydronephrosis, stone history, stone size, preoperative stent placement, preoperative positive urine culture, and procedure time. A random effects meta-analysis model with inverse variance weighting was used where the statistic of interest was the odds ratio for dichotomous variables and the mean difference for continuous outcomes. In 13 studies (5 prospective) with 5597 patients, the pooled incidence of postoperative urosepsis was 5.0% (95% confidence interval: 2.4-8.2). Six risk factors were statistically associated with increased postoperative urosepsis risk-preoperative stent placement (odds ratio = 3.94, < 0.001, 6 studies), positive preoperative urine culture (odds ratio = 3.56, < 0.001, 6 studies), ischemic heart disease (odds ratio = 2.49, = 0.002, 2 studies), older age (mean difference = 2.7 years, = 0.002, 6 studies), longer procedure time (mean difference = 9 minutes, = 0.02, 1 study), and diabetes mellitus (odds ratio = 2.04, = 0.04, 6 studies). Current evidence suggests that among patients undergoing URS for treatment of stone disease, the risk of postoperative urosepsis was 5.0%. Older age, diabetes mellitus, ischemic heart disease, preoperative stent placement, a positive urine culture, and longer procedure time were associated with increased postoperative urosepsis risk. These results will assist urologists with preoperative risk stratification before ureteroscopic procedures.
尿脓毒症是输尿管镜治疗结石病的严重潜在并发症,但这种并发症的危险因素尚不清楚。本系统评价和荟萃分析的目的是确定输尿管镜治疗结石病后尿脓毒症的潜在危险因素。我们对 Medline、Embase 和 Cochrane 对照试验中心注册数据库进行了系统检索,以寻找至少有一个前瞻性定义的输尿管镜术后尿脓毒症危险因素的研究。仅报告孤立发热、尿路感染 (UTI) 或汇总感染并发症的研究被排除在外。本综述评估的危险因素包括年龄、性别、体重指数、糖尿病、缺血性心脏病、近期 UTI、脓尿、肾积水、结石史、结石大小、术前支架置入、术前阳性尿培养和手术时间。使用具有倒数方差加权的随机效应荟萃分析模型,其中感兴趣的统计数据是二分类变量的优势比和连续结果的均数差。在 13 项研究(5 项前瞻性)中,有 5597 名患者,术后尿脓毒症的总发生率为 5.0%(95%置信区间:2.4-8.2)。有 6 个危险因素与术后尿脓毒症风险增加相关-术前支架置入(优势比=3.94, < 0.001,6 项研究)、术前阳性尿培养(优势比=3.56, < 0.001,6 项研究)、缺血性心脏病(优势比=2.49, = 0.002,2 项研究)、年龄较大(均数差=2.7 岁, = 0.002,6 项研究)、手术时间较长(均数差=9 分钟, = 0.02,1 项研究)和糖尿病(优势比=2.04, = 0.04,6 项研究)。目前的证据表明,在接受输尿管镜治疗结石病的患者中,术后尿脓毒症的风险为 5.0%。年龄较大、糖尿病、缺血性心脏病、术前支架置入、尿培养阳性和手术时间较长与术后尿脓毒症风险增加相关。这些结果将有助于泌尿科医生在输尿管镜术前进行风险分层。